|
|
|
| Webinar: Supporting Efficient mAb Development with a Flexible Downstream Purification Toolkit | Accelerating antibody therapeutics to market requires more than upstream performance. As mAb formats grow more complex, downstream purification must evolve beyond traditional approaches. This webinar explores flexible purification strategies, advanced chromatography options, and buffer optimization techniques to improve yield, purity, and robustness. Learn how to streamline process development and build a purification toolkit that supports faster biologics manufacturing. Click here to learn more. |
|
|
|
|
By Monika Sharma, EOSPA LLC | IV → SC is a system design challenge. Success depends on aligning formulation, device, manufacturing, and clinical strategy early to avoid costly failures and redesigns. | |
|
|
|
| Small Volume ATMP Cryo-Freezing Strategies | White Paper | CPC Biotech | Discover best practices for cryopreserving small-volume ATMPs, focusing on sterility, viability, and efficiency with advanced containers and packaging. |
|
|
| Challenges And Solutions In Lyophilization Development For ADCs | White Paper | By Gregory Sacha, Ph.D., Simtra BioPharma Solutions | Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for stability and efficient manufacturing. |
|
|
| Product Recovery Study For Fill Finish Applications | Application Note | Thermo Fisher Scientific | Surge bags are essential to fill finish efficiency, but poor drainage can cause costly product loss. Learn how drainage testing helps identify high-performance bags that maximize recovery and reduce waste. |
|
|
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
|
|
|
| Why Anion Exchange Chromatography Rules At Scale | Article | KNAUER | Read about how anion exchange chromatography delivers high loading capacity and clinical-grade purity while addressing common scale-up challenges like aggregation and equipment longevity. |
|
|
| Eliminate Downstream Bottlenecks In Antibody-Based Therapies | Article | By Chase Snyder, AGC Biologics; and William Barrett, W.L. Gore & Associates | Organizations seeking greater efficiency within their downstream purification processes are well-served in considering a single-use, membrane-based solution in lieu of resin-based purification columns. |
|
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|